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Abstract
Aims/hypothesis The aim of this work was to test whether the
mid-adolescent peak in insulin resistance (IR) and trends in
other metabolic markers are influenced by long-term exposure
to physical activity.
Methods Physical activity (7 day ActiGraph accelerometry),
HOMA-IR and other metabolic markers (glucose, fasting in-
sulin, HbA1c, lipids and BP) were measured annually from
age 9 years to 16 years in 300 children (151 boys) from the
EarlyBird study in Plymouth, UK. The activity level of each
child was characterised, with 95% reliability, by averaging
their eight annual physical activity measures. Age-related
trends in IR and metabolic health were analysed by multi-
level modelling, with physical activity as the exposure mea-
sure (categorical and continuous) and body fat percentage
(assessed by dual-energy X-ray absorptiometry) and pubertal
status (according to age at peak height velocity and Tanner
stage) as covariates.
Results The peak in IR at age 12–13 years was 17% lower
(p<0.001) in the more active adolescents independently of
body fat percentage and pubertal status. However, this differ-
ence diminished progressively over the next 3 years and had
disappeared completely by the age of 16 years (e.g. difference
was −14% at 14 years, −8% at 15 years and +1% at 16 years;
‘physical activity×age2’ interaction, p<0.01). Triacylglycerol
levels in girls (−9.7%, p=0.05) and diastolic blood pressure in
boys (−1.20 mmHg, p=0.03) tended to be lower throughout
adolescence in the more active group.
Conclusions/interpretation Our finding that physical activity
attenuates IR during mid-adolescence may be clinically im-
portant. It remains to be established whether the temporary
attenuation in IR during this period has implications for the
development of diabetes in adolescence and for future meta-
bolic health generally.
Keywords Adolescence . Children . Exercise . Insulin
resistance .Metabolic health . Physical activity . Teenagers
Abbreviations
DBP Diastolic BP
DXA Dual-energy X-ray absorptiometry
IR Insulin resistance
MAP Mean arterial pressure
MET Metabolic equivalent
SBP Systolic BP
Introduction
The prevalence of childhood obesity has increased in much of
the industrialised world over the past two decades with one-in-
six children in the UK [1] and USA [2] currently being obese.
This is of concern because obesity appears to underlie much of
the insulin resistance (IR) that leads to diabetes, cardiovascu-
lar disease and the metabolic syndrome [3]. The cause of
obesity is multifactorial but ultimately results from a chronic
imbalance between energy intake and energy expenditure.
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Physical activity accounts for around 35–45% of energy ex-
penditure in children and adolescents [4] and, being potential-
ly modifiable, it is often incorporated intuitively into
programmes designed to reduce childhood obesity.
Systematic reviews have shown that activity interventions
in children lead to only small improvements in body mass and
body fat [5–7]. However, other reviews have shown that ac-
tivity interventions (especially those of at least moderate-
intensity activity) consistently reduce IR and improve meta-
bolic health, even when body fat is unchanged [8, 9].
Together, these findings suggest that physical activity might
improve IR and metabolic health via two mechanisms—one
through the lowering of body fat, one independent of body fat.
Observational studies showing an inverse association between
physical activity and IR, even after controlling for body mass
and body fat, support this conclusion [8]. The association
tended to be found only in adolescent children, while the ev-
idence in pre-adolescent children was not so clear [8]. Our
own (EarlyBird) data show no association between activity
and IR in pre-adolescence (age 8 years) [10]. The higher levels
of IR in the adolescent age group that we and others have
reported [11–13] may explain the emergence of an association
with physical activity around that time.
IR appears to be a factor in both type 1 and type 2 diabetes
[14]. An understanding of the metabolic response to physical
activity at an age when the incidence of childhood diabetes
peaks could be important in gauging the role of physical ac-
tivity in diabetes prevention. Using annual recordings of ob-
jectively measured physical activity, body composition, insu-
lin, glucose, lipids and blood pressure collected from a single
cohort throughout the entire period of adolescence (age 9–
16 years), we have sought to establish when, and to what
extent, physical activity in contemporary children has an im-
pact on IR and other markers of metabolic health.
Methods
Design, setting and participants
EarlyBird is a non-intervention prospective cohort study of
347 healthy children (174 boys, 173 girls) recruited from 53
primary schools in Plymouth, UK (307 children were recruit-
ed at age 5 years in 2000 and 2001 and 40 more at age 9 years
in 2004 and 2005 to redress a sex imbalance). An initial sam-
ple size of 307 was calculated in order to deem even a small
association (r=0.16, R2=2.5% [15]) between physical activity
and obesity-related health outcomes statistically significant at
the 5% level (p<0.01) with 80% power. Most (98.6%, n=342)
were of European descent and five children (1.5%) were of
mixed race, reflecting the racial mix of the city (1.6% accord-
ing to the 2001 census [16]). The cohort underwent measure-
ments annually (time between visits: mean=1.0 year, SD
0.1 years). Data from pre-puberty (age 5–8 years) have already
been reported [10]; the present report covers the subsequent
eight annual time points spanning all of adolescence from the
age of 9 years to 16 years (early adolescence ~9–11 years, mid-
adolescence ~12–14 years, late adolescence ~15–16 years).
Written consent from the parent and assent from the child
was obtained at each visit. Ethical approval was obtained from
the Plymouth Local Research Ethics Committee (South and
West Devon Health Authority) in 1999 and updated regularly.
The study’s rationale, recruitment procedures and protocol
have been reported in detail elsewhere [17].
Main outcome and exposure measures
Physical activity Activity was measured objectively using
ActiGraph accelerometers (Model 7164 – formerly MTI/CSA;
ActiGraph, Fort Walton Beach, FL, USA). The particular
model that we used offers good technical reproducibility
[18] and its data correlate well with those of free-living activ-
ity-related energy expenditure obtained using indirect calo-
rimetry [19, 20]. The accelerometers were worn around the
child’s waist and were set to run continuously for 7 days at
each annual time point. To eliminate any acute effect that
physical activity may have on the measurement of metabolic
health, the accelerometers were worn during the week that
followed the measurements. The children were asked to wear
the accelerometer every day from the time they got out of bed
in the morning to the time they went to bed at night, removing
it only for any water-based activity (e.g. swimming, bathing,
showering, etc.). Only recordings that captured at least 4 days
monitoring (incorporating at least 9 h wear time and including
at least one weekend day) were included in the analyses as
four is the minimum number of days required to achieve 70%
reliability [21]. TheActiGraph 7164 records change in vertical
acceleration (expressed as ‘counts’) 600 times per minute,
which for the present study was integrated into 1 min epochs.
Two components of physical activity were adduced from the
ActiGraph data at each annual time point: time spent in
moderate-and-vigorous-intensity activity (expressed as min/
day) and total volume of activity (expressed as counts/min).
Moderate-and-vigorous physical activity was the measure of
physical activity used in the main analysis as the primary
exposure measure, while total volume of activity was used
only in the sensitivity analysis. The recommended ‘counts/
min’ threshold varies widely for the term ‘moderate-and-vig-
orous’ activity [22]; for this study the threshold was specific to
3 metabolic equivalents (METs), deemed by the UK govern-
ment to be the lower limit of moderate activity [23]. Two
studies that measured energy expenditure and ActiGraph
counts simultaneously in children have shown that 3 METs
is equivalent to ~2,500 ActiGraph counts/min [19, 20]. This
cut-point is very similar to the one that was reported by Trost
et al as being the most appropriate of the five published cut-
Diabetologia
points for ‘moderate-and-vigorous’-intensity activity [24].
The children and their parents were asked to record periods
when the child removed the accelerometer during waking
time, so that false periods of inactivity could be identified.
The sensitivity of each accelerometer was measured by a
motorised turntable [18]. Seasonality was measured by the
number of relevant daylight hours (between 08:00 hours and
22:00 hours) specific to Plymouth, UK for the week the ac-
celerometer was worn [25].
Each measure of physical activity was adjusted to the mean
number of daylight hours (10.5 h/day) and to the mean
ActiGraph sensitivity. Reported periods of non-compliance
and intervals of zero accelerometer counts lasting 17 consec-
utive minutes or more (assumed to be unreported non-
compliance) were replaced with the mean accelerometer
counts recorded at the same clock time on the other week or
weekend days. The 17 min threshold is based on an unpub-
lished calibration study of 30 children that we (B. S. Metcalf
and T. J. Wilkin) carried out and is between the 20 min thresh-
old recommended in young children [26] and the 10 min
threshold that others have applied to similar-aged children
[27].
Metabolic variables A venous blood sample was taken at
~09:00 hours after the children had fasted overnight. Serum
insulin was measured using an Immulite analyser (Diagnostic
Products Corporation, Los Angeles, CA, USA). The cross-
reactivity with proinsulin was <1%, the inter-assay CV was
~9% and the detection limit of the assay was 2.0 mU/l
(~14 pmol/l). Glucose was measured using a Cobas Integra
700 analyser (Roche Diagnostics, Burgess Hill, UK), with
inter-assay CV being ~2%. The values for insulin and glucose
were used to derive a measure of IR using the HOMA-IR
program [28], downloaded from the University of Oxford
Diabetes Trials Unit website (www.dtu.ox.ac.uk). HOMA-IR
has been validated against the euglycaemic clamp (r=0.91) in
healthy youths [29]. HbA1c levels were measured by automat-
ed high-performance liquid chromatography using a Menarini
Biomen HA 8140 analyser (Menarini, High Wycombe, UK).
Triacylglycerol, cholesterol and HDL-cholesterol were mea-
sured on a Cobas Integra 700 analyser; LDL-cholesterol and
the cholesterol/HDL ratio were derived accordingly. Systolic
and diastolic BP (SBP and DBP, respectively) was taken with
a semi-automated sphygmomanometer and the mean arterial
pressure (MAP) was calculated as (SBP+[2×DBP])/3.
Covariates Each year, the percentage body fat of the partici-
pants was measured from a whole-body dual-energy X-ray
absorptiometry (DXA) scan performed with a Prodigy
Advance fan beam densitometer (GE Healthcare, Little
Chalfont, UK). Pubertal status was accounted for with two
measures—age at peak height velocity (calculated from six-
monthly measurements of height) and pubic hair development
(self-reported using the Tanner stage 1–5 drawings where
1=no pubic hair).
Statistical analysis
The overall long-term physical activity exposure level of each
child was characterised by averaging their moderate-and-
vigorous activity measures across all eight annual time points.
In doing so, the children were positioned/ranked according to
how active they had been throughout the entire adolescent
period with 95% reliability (compared with just 70% reliabil-
ity achieved with one annual measure of physical activity). As
moderate-and-vigorous activity changed little from the age of
9 years to 16 years, averaging was carried out on min/day
data, but for total volume of activity, which declined during
adolescence, the data were standardised into age- and sex-
specific z scores before being averaged. The average
moderate-and-vigorous activity level was analysed both as a
continuous variable and, for ease of presentation and interpre-
tation, as a categorical variable (those above the sex-specific
median [boys 50 min/day; girls 35 min/day] were labelled as
‘more active’ and those below as ‘less active’).
Multi-level modelling is ideal for the analyses of
longitudinal/repeated measures data and was therefore used
in this study to determine whether the age-related changes in
metabolic health differed depending on the overall activeness
of the child. Multi-level modelling produces more robust
model coefficients than standard cross-sectional techniques
as it accounts for between-child variation by modelling
within-child trajectories. This is achieved by entering age
(and any relevant polynomials of age) into the model as a
random effect, thus allowing the age-related trajectories to
vary for each individual child. The age-related trends in the
metabolic variables were not linear and therefore accounted
for by polynomials of age. Age (continuous) was therefore
centred on the mean age calculated across all annual time
points (centred age=0 at 12.5 years) to aid the interpretation
of such polynomials. Age was entered into the model as a
fixed effect and as a random effect, then polynomials of in-
creasing order were added one by one (age2, age3, age4 and so
on) again as both fixed and random effects. Random coeffi-
cients of the polynomials were retained provided that their
variance components were positive. Fixed effects polynomials
continued to be added until they were non-significant to en-
sure the best fitting age-related model [30]. Average physical
activity (categorical or continuous) was then entered into the
model as a main effect and as an interaction term with age and
the polynomials of age. If one ormore of these ‘activity×agep’
interaction terms were significant, a likelihood ratio test was
performed to determine whether the inclusion of the interac-
tion terms improved the overall fit of the model. If the inter-
action term was not significant, or not close to being signifi-
cant (p>0.10), the model was re-run without that interaction.
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The analysis was carried out for both sexes separately and
combined and with and without controlling for any differ-
ences there might be in body fat percentage and pubertal status
between the activity groups.
The distributions of insulin, IR and triacylglycerol were
positively skewed in both sexes and were therefore log-
transformed to ensure that the residuals did not violate the
assumption of normality. The physical activity coefficient ob-
tained whenmodelling these three variables was consequently
back-transformed (with the exponential function) so that it
represented the percentage difference in the outcome variable
rather than the absolute difference on a logged scale. For all
other metabolic variables, the activity coefficient represented
the absolute difference. All analyses were performed using
IBM SPSS version 19.0 (IBM, Armonk, NY, USA).
Results
Table 1 reports the characteristics of the cohort at baseline (age
9 years). Of note are the uniformity of age within and between
the sexes, the higher body fat percentage and IR of the girls,
their earlier attainment of peak height velocity and their lower
levels of adolescent physical activity.
Most of the children included in this analysis were mea-
sured at most of the annual time points. Thus, 88%, 87% and
75%, respectively, provided data on body fat percentage, IR
and physical activity on at least six of the eight annual occa-
sions from 9 years to 16 years. There were no significant
differences for any of these three measures at 9 years between
those who provided data on most occasions and those who did
not (all p>0.4). Consequently, all cases were included in the
analysis as multi-level modelling makes the most of the data
available and retains participants who might otherwise be lost
for lack of one or more data points.
IR and glucose control according to physical activity
Of the metabolic variables specific to glucose control
(Table 2), neither fasting glucose nor HbA1c were associated
with physical activity, but fasting insulin and IR were, even
after controlling for body fat % and pubertal status.
The age-related trend in IR for the entire cohort from
9–16 years followed an inverted U-shaped, quadratic curve
(modelled by a second-order polynomial, age+age2) with IR
being at a similar level at ages 9 years and 16 years and
peaking around 12–13 years. Figure 1 shows that the peak
in IR was lower in the ‘more active’ group than the ‘less
active’ group. In the unadjusted model, the ‘activity group’
main effect and the ‘activity group×age2’ interaction were
both statistically significant (p<0.001 and p<0.01 respective-
ly, Table 2). The coefficient for the activity group main effect
indicated that IR was 26.2% lower in the ‘more active’ group
than in the ‘less active’ group at age 12.5 years (centred
age=0) and the ‘activity group×age2’ interaction coefficient
indicated that this difference decreased by ‘1.5%multiplied by
the number of years squared before or after age 12.5 years’—
e.g. at 14 years the difference was −22.8% (−26.2%+
[1.5 years2×1.5%]), at 15 years it was −16.8% and at 16 years
it was −7.8% in the unadjusted model.
Given that the percentage of body fat was slightly, though
consistently, higher in the less active than in the more active
group throughout (by ~4% in boys, ~3% in girls, p value
ranging from <0.01 to 0.15 for all time points) and that body
fat % is associated with IR (p<0.001 at each time point), it
was appropriate to enter body fat % into the model as a po-
tential covariate. Although both measures of pubertal status
tended to be similar between the activity groups, these were
also entered as covariates because at least one of the measures
(sometimes both) was associated with IR at each time point.
The inclusion of these covariates only partly explained the
age-varying effect of physical activity on IR. Results from
the adjusted model indicated that IR was still significantly
lower in the ‘more active’ group than in the ‘less active’ group
at age 12.5 years (by 17.0%, p<0.001, compared with 26.2%
without covariates—body fat % reduced it by ~7%, pubertal
stage by ~2%). They also showed that the difference still di-
minished by a function of age2 either side of age 12.5 years
(‘activity group×age2’ interaction coefficient was 1.5%,
p<0.01; likelihood ratio test for inclusion of interaction terms
with χ2 (7, 2), p=0.03). For example, by the ages of 14 years,
15 years and 16 years the difference had fallen to −13.6%,
−7.6% and +1.4%, respectively. For both the adjusted and un-
adjusted models the activity group difference in IR and insulin
at age 12.5 years was slightly greater for girls than for boys,
though this was not statistically significant (‘activity group×
age2×sex’ interaction, both p>0.2).
The findings obtained from the analysis of moderate-and-
vigorous activity as a continuous variable were, as expected,
very similar to when it was analysed as a categorical variable.
For example, for every extra 15 min/day spent in moderate-
and-vigorous activity, IR was 5.5% lower (95% CI −9.5%,
−1.3%, p=0.01) at age 12.5 years independent of body fat
% and pubertal status. The ‘activity×age2’ interaction term
again reflected a reduction in the difference in IR either side
of age 12.5 years (interaction coefficient 0.5%, 95% CI 0.1%,
0.9%, p=0.02) so by age 16 years the benefit had completely
disappeared.
Fasting insulin correlates strongly with HOMA-IR in chil-
dren (r>0.9 here) so, not surprisingly, the activity-related find-
ings for insulin were almost identical to those found for IR.
Lipids and BP according to physical activity
Of the lipid variables reported in Table 3, only triacylglycerol
in girls (p=0.05), not boys (p=0.51), was associated with
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physical activity independently of body fat % and pubertal
status. The ‘more active group’ main effect coefficient in the
adjusted model indicated that triacylglycerol was 9.7% lower
in the more active girls than in the less active girls across the
entire age range. Findings were similar when activity was
analysed as a continuous variable, although the difference
was not statistically significant (in the adjusted model, triac-
ylglycerol was 4.1% lower for every additional 15 min/day of
moderate-and-vigorous activity, p=0.08).
The DBP of boys (p=0.03) but not girls (p=0.93) was
associated with physical activity independently of body fat
% and pubertal status. The ‘more active group’ main effect
coefficient in the adjusted model indicated that DBP was
1.20 mmHg lower in the ‘more active’ boys than in the ‘less
active’ boys across the entire age range. The corresponding
finding derived from the analysis of physical activity as a
continuous variable was similar, though the difference did
not reach statistical significance (in the adjusted model, DBP
was 0.41 mmHg lower for every additional 15 min/day of
moderate-and-vigorous activity, p=0.11)
Sensitivity analysis
Re-running the multi-level models with total volume of phys-
ical activity as the main exposure variable produced very sim-
ilar findings to those reported above for moderate-and-
Table 1 Participant characteris-
tics (at age 9 years visit unless
otherwise stated)
Characteristic Boys Girls
N at 9 years visit 151 149
N at 10 years visit 151 149
N at 11 years visit 151 143
N at 12 years visit 146 137
N at 13 years visit 145 136
N at 14 years visit 142 136
N at 15 years visit 141 136
N at 16 years visit 141 136
Age, years 8.9 (0.3) 8.8 (0.3)
BMI, kg/m2 17.1 (2.6) 18.1 (2.9)
Body fat, % 18.6 (8.7) 25.7 (8.1)
Age at peak height velocity, years 13.1 (0.7) 11.6 (1.1)
Pubic hair development, % (n/N)
No pubic hair (TS=1) at 9 years 97 (142/147) 93 (136/147)
Adult type hair (TS ≥4) at 16 years 94 (132/140) 83 (113/136)
Glucose control and IR
Glucose, mmol/l 4.8 (0.4) 4.7 (0.3)
Insulin, pmol/la 26.4 (16.0–38.9) 35.4 (25.7–49.3)
HOMA-IRa 0.54 (0.33–0.81) 0.75 (0.53–1.02)
HbA1c, % 5.2 (0.2) 5.2 (0.2)
HbA1c, mmol/mol 33.8 (2.4) 33.4 (2.2)
Lipids and blood pressure
Triacylglycerol, mmol/la 0.52 (0.41–0.68) 0.63 (0.46–0.80)
Total cholesterol, mmol/l 4.3 (0.7) 4.4 (0.7)
LDL-cholesterol, mmol/l 2.2 (0.6) 2.3 (0.7)
HDL-cholesterol, mmol/l 1.9 (0.4) 1.8 (0.4)
Cholesterol/HDL ratio 2.4 (0.5) 2.6 (0.6)
SBP, mmHg 101 (7) 100 (7)
DBP, mmHg 63 (5) 63 (6)
MAP 75 (5) 75 (6)
Physical activity (mean 9 years to 16 years)
Moderate-and-vigorous physical activity (min/day)a 50 (40–65) 35 (28–45)
Data are presented as mean (SD) unless stated otherwise
aMedian (interquartile range)
TS=Tanner stage
Diabetologia
T
ab
le
2
D
if
fe
re
nc
es
in
in
su
lin
re
si
st
an
ce
an
d
gl
uc
os
e
co
nt
ro
lb
et
w
ee
n
th
e
m
or
e
ac
tiv
e
an
d
le
ss
ac
tiv
e
ad
ol
es
ce
nt
s
O
ut
co
m
e
va
ri
ab
le
M
od
el
te
rm
U
na
dj
us
te
d
A
dj
us
te
d
fo
r
bo
dy
fa
t%
an
d
pu
be
rt
al
st
at
us
A
ll
B
oy
s
G
ir
ls
A
ll
B
oy
s
G
ir
ls
H
O
M
A
-I
R
a,
b
(r
el
at
iv
e
%
)
M
or
e
ac
tiv
e
gr
ou
p
(m
ai
n
ef
fe
ct
at
12
.5
ye
ar
s)
−2
6.
2
(−
36
.8
,−
15
.6
)
p
<
0.
00
1
−2
2.
0
(−
37
.1
,−
6.
8)
p
<
0.
01
−3
0.
6
(−
45
.0
,−
16
.2
)
p
<
0.
00
1
−1
7.
0
(−
26
.1
,−
8.
0)
p
<
0.
00
1
−1
4.
2
(−
26
.8
,−
1.
5)
p
=
0.
04
−1
9.
1
(−
32
.2
,−
5.
9)
p
<
0.
01
M
or
e
ac
tiv
e
gr
ou
p
×
ag
e2
(i
nt
er
ac
tio
n
ef
fe
ct
)
1.
5
(0
.5
,2
.4
)
p
<
0.
01
1.
1
(−
0.
2,
2.
4)
p
=
0.
10
1.
8
(0
.6
,3
.1
)
p
<
0.
01
1.
5
(0
.6
,2
.4
)
p
<
0.
01
1.
3
(0
.1
,2
.6
)
p
=
0.
04
1.
7
(0
.6
,2
.9
)
p
<
0.
01
In
su
lin
a,
b
(r
el
at
iv
e
%
)
M
or
e
ac
tiv
e
gr
ou
p
(m
ai
n
ef
fe
ct
at
12
.5
ye
ar
s)
−2
6.
4
(−
37
.0
,−
15
.7
)
p
<
0.
00
1
−2
2.
1
(−
37
.2
,−
6.
9)
p
<
0.
01
−3
0.
3
(−
45
.3
,−
15
.3
)
p
<
0.
00
1
−1
7.
0
(−
26
.0
,−
7.
9)
p
<
0.
00
1
−1
4.
1
(−
26
.7
,−
1.
5)
p
=
0.
05
−1
9.
0
(−
32
.1
,−
5.
9)
p
<
0.
01
M
or
e
ac
tiv
e
gr
ou
p
×
ag
e2
(i
nt
er
ac
tio
n
ef
fe
ct
)
1.
4
(0
.5
,2
.3
)
p
<
0.
01
1.
1
(−
0.
2,
2.
4)
p
=
0.
10
1.
7
(0
.4
,3
.0
)
p
<
0.
01
1.
5
(0
.6
,2
.3
)
p
<
0.
01
1.
3
(0
.1
,2
.6
)
p
=
0.
04
1.
7
(0
.5
,2
.9
)
p
<
0.
01
G
lu
co
se
c
(m
m
ol
/l)
M
or
e
ac
tiv
e
gr
ou
p
(m
ai
n
ef
fe
ct
at
al
la
ge
s)
−0
.0
3
(−
0.
08
,0
.0
3)
p
=
0.
33
0.
01
(−
0.
07
,0
.0
8)
p
=
0.
85
−0
.0
6
(−
0.
13
,0
.0
1)
p
=
0.
08
−0
.0
1
(−
0.
07
,0
.0
5)
p
=
0.
71
0.
01
(−
0.
08
,0
.1
0)
p
=
0.
80
−0
.0
3
(−
0.
11
,0
.0
4)
p
=
0.
37
H
bA
1
cc
(a
bs
ol
ut
e
%
)
M
or
e
ac
tiv
e
gr
ou
p
(m
ai
n
ef
fe
ct
at
al
la
ge
s)
−0
.0
2
(−
0.
06
,0
.0
3)
−0
.0
2
(−
0.
08
,0
.0
4)
−0
.0
1
(−
0.
07
,0
.0
5)
−0
.0
2
(−
0.
06
,0
.0
3)
−0
.0
2
(−
0.
08
,0
.0
4)
−0
.0
1
(−
0.
07
,0
.0
5)
H
bA
1
cc
(m
m
ol
/m
ol
)
M
or
e
ac
tiv
e
gr
ou
p
(m
ai
n
ef
fe
ct
at
al
la
ge
s)
−0
.1
7
(−
0.
63
,0
.2
8)
p
=
0.
45
−0
.2
1
(−
0.
88
,0
.4
6)
p
=
0.
54
−0
.1
4
(−
0.
77
,0
.5
0)
p
=
0.
67
−0
.1
7
(−
0.
65
,0
.2
9)
p
=
0.
48
−0
.2
0
(−
0.
88
,0
.4
9)
p
=
0.
57
−0
.0
9
(−
0.
74
,0
.5
6)
p
=
0.
78
D
at
a
ar
e
pr
es
en
te
d
as
m
od
el
co
ef
fi
ci
en
t(
95
%
C
I)
an
d
p
va
lu
e
M
or
e
ac
tiv
e
gr
ou
p:
bo
ys
≥5
0
m
in
/d
ay
an
d
gi
rl
s
≥3
5
m
in
/d
ay
of
m
od
er
at
e-
an
d-
vi
go
ro
us
ph
ys
ic
al
ac
tiv
ity
.A
ge
2
re
fe
rs
to
‘t
he
nu
m
be
ro
fy
ea
rs
to
/f
ro
m
ag
e
12
.5
ye
ar
s,
al
ls
qu
ar
ed
’.
T
he
‘m
or
e
ac
tiv
e
gr
ou
p
×
ag
ep
,
in
te
ra
ct
io
n
w
as
on
ly
re
po
rt
ed
if
it
w
as
,o
r
al
m
os
tw
as
,s
ta
tis
tic
al
ly
si
gn
if
ic
an
t(
p
≤0
.1
).
A
n
an
al
ys
is
of
al
lc
hi
ld
re
n
to
ge
th
er
co
nt
ro
lli
ng
fo
r
se
x,
w
as
on
ly
ca
rr
ie
d
ou
ti
f
th
e
‘M
or
e
ac
tiv
e
gr
ou
p
×
se
x’
in
te
ra
ct
io
n
te
rm
w
as
no
ts
ta
tis
tic
al
ly
si
gn
if
ic
an
t(
p
>
0.
05
)
a
C
oe
ff
ic
ie
nt
s
re
pr
es
en
tt
he
pe
rc
en
ta
ge
,r
at
he
r
th
an
ab
so
lu
te
,d
if
fe
re
nc
e
in
th
e
ou
tc
om
e
va
ri
ab
le
b
N
on
-l
in
ea
r
ag
e-
re
la
te
d
tr
en
d
ac
co
un
te
d
fo
r
by
a
se
co
nd
-o
rd
er
po
ly
no
m
ia
lo
f
ag
e
(e
.g
.a
ge
+
ag
e2
)
c
N
on
-l
in
ea
r
ag
e-
re
la
te
d
tr
en
d
ac
co
un
te
d
fo
r
by
a
th
ir
d-
or
de
r
po
ly
no
m
ia
lo
f
ag
e
(e
.g
.a
ge
+
ag
e2
+
ag
e3
)
Diabetologia
vigorous activity, although the magnitudes of the significant
differences were marginally smaller. For example, when
grouped by total volume of activity, IR was 14.9% lower
(p<0.001, adjusted model) at the age of 12.5 years in the more
active group as compared with 17.0% when grouped by
moderate-and-vigorous activity. However, the benefit for both
had disappeared by the age of 16 years (‘activity group×age2’
interaction: total activity=1.3%, p=0.01; moderate-and-
vigorous activity=1.5%, p<0.01). When analysed for total
volume of activity, triacylglycerol in girls was 6.5% lower
(p=0.27) and DBP in boys was 1.15 mmHg lower (p=0.04)
in the more active group (compared with 9.7% and
1.20 mmHg, respectively, for moderate-and-vigorous
activity).
Discussion
Principal findings
Physical activity attenuated the mid-adolescent peak in IR but
the effect diminished progressively over the next few years
and had disappeared completely by late adolescence. The tem-
porary effect on IR was similar in both sexes and was inde-
pendent of body fat and pubertal stage. Smaller, yet more
permanent, benefits were seen in two other metabolic markers
with triacylglycerol (in girls only) and DBP (in boys only)
being marginally lower in the more physically active children
throughout the whole of adolescence.
Strengths and weaknesses
Many studies now use accelerometers to measure physical
activity objectively, though most rely on a single sampling
period of 3–7 days, which we have shown previously is only
~70% reliable [31]. In this report, physical activity during
adolescence was characterised with 95% reliability by averag-
ing the eight annual measures of 7 day accelerometry. High
reliability optimises the detection of even subtle relationships
between long-term exposure to physical activity and changes
in metabolic health. Fasting annual blood samples collected
throughout adolescence in the same cohort enabled us to study
trends in metabolic variables with high precision, and the uni-
form age of the cohort maximised resolution of time-related
events. The study was nevertheless based on a single popula-
tion of white adolescents living in the south-west of England.
The homogeneity of race may have been helpful in revealing
the findings we have reported but may limit the
generalisability of the findings to other racial groups.
Strengths and weaknesses in relation to other studies
and any differences in their results
Few longitudinal studies have examined IR and metabolic
health in relation to objectively measured activity during ad-
olescence and no studies have examined them in relation to
the rise and fall of IR over that period. Telford and colleagues
reported a longitudinal association between physical activity
and IR from age 8 years to 12 years in boys (p=0.04) [32], but
did not find any cross-sectional association in the same boys at
age 8 years or 10 years [33]. These findings are consistent
with those of the current study as they imply that the relation-
ship emerges as the boys approach mid-adolescence, when IR
is at its highest. However, Telford et al did not make any
measurements in children beyond the age of 12 years to con-
firm the late-adolescent fall in IR and the diminishing associ-
ation with activity. Jago and colleagues reported a longitudinal
association between physical activity and IR based on two
points, at 9 years and 15 years [34], but, with limited time
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Fig. 1 Age-related changes in IR throughout adolescence, according to
physical activity in boys (a) and girls (b). Black lines, more active group
(time spent in moderate-and-vigorous physical activity above the median
of 50 and 35 min/day for boys and girls, respectively); grey lines, less
active group (below the median). Data points represent the back-
transformed age coefficients of logged IR for each activity group predict-
ed by a longitudinal multi-level model (with age treated as a categorical
variable for ease of presentation) unadjusted for covariates. Error bars
represent the 95% CI of these age-related coefficients
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points, were not able to explore the age-related interaction
found in the present study.
Most cross-sectional studies carried out in adolescents have
incorporated a wide age range, making the interpretation of a
single correlation difficult. A recent review reported that all
nine cross-sectional studies using objective measures of phys-
ical activity found an (albeit small) inverse relationship between
activity and IR (r~−0.2 to −0.1) [8]. While the single overall
correlation produced by the present dataset (9–16 years
[r~−0.11]) falls within this range, the age-specific correlations
we found provided a strong indication that this association var-
ied with age (e.g. for boys, r=−0.17 at 12 years and −0.02 at
16 years; for girls, r=−0.31 at 12 years and −0.03 at 16 years).
More recently, a large cross-sectional analysis of some 5,000
children aged 4–18 years reported a significant inverse associ-
ation between physical activity and fasting insulin (β=−0.028,
95% CI −0.038, −0.017) [35]. Unfortunately, the authors did
not report age-specific associations, so it was unclear whether
the strength of the association changed across the age range. A
recent review of exercise-training trials did show that the im-
pact on IR was slightly lower (though the difference was not
statistically significant) at the later stages of puberty [9].
Implications, unanswered questions and possible
explanations
These findings have implications for future interventions de-
signed to improve the insulin sensitivity of children. An inter-
vention that is deemed unsuccessful in 16-year-olds (when IR
levels are low) may actually have led to significant reductions
in IR had it been delivered to 12- to 13-year-olds (when IR
levels were much higher). We do not know why IR should be
attenuated by physical activity only in mid-adolescence. One
possibility is that by the age of 16 years, when IR returns to its
pre-adolescent levels [36], many children are once again suf-
ficiently sensitive to the action of insulin to render any further
change in IR, through increased activity, difficult to achieve. It
is possible that the rise-and-fall cycle in IR during the course
of adolescence reflects the ‘hunting’ behaviour that
characterises a control loop under stress [37]. In such circum-
stances, the biological control loop would be expected to os-
cillate spontaneously between tissue function and diminishing
beta cell reserve in order to defend blood glucose [38]. These
oscillations could be more closely related to age than to pu-
berty itself, as we have suggested previously [11], explaining
the link to adolescence and limited interaction with pubertal
stage. The higher insulin levels in the less active children
during mid-adolescence will have put a greater demand on
the beta cells over that period. It could be hypothesised that
this greater demand on the beta cells during adolescence has a
negative impact on the cells’ function in adulthood, leading to
an increased and/or accelerated risk of diabetes in later life.
We do not know why the improvements in triacylglycerol
and DBP were sex specific or why similar improvements did
not appear in the other lipid or BP measures. Nevertheless, we
feel that the activity-related improvements in triacylglycerol
(girls only) and DBP (boys only) demonstrate that the meta-
bolic benefits of being more active are not simply restricted to
IR.
Conclusions
Our findings may be important clinically, as physical activity
appears to attenuate IR and insulin demand during mid-
adolescence. It remains to be established whether the tempo-
rary attenuation in IR during mid-adolescence has implications
for the development of diabetes in adolescence and adulthood,
and for future metabolic health generally.
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